TScan Therapeutics (TCRX) EBITDA (2020 - 2026)
TScan Therapeutics' EBITDA came in at -$29.79 million for Q2 2026, compared with -$37.96 million a year earlier.
Powered by 
Analysis
TScan Therapeutics (TCRX) EBITDA (2020 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, TScan Therapeutics reported EBITDA of -$117.66 million; for FY2025, it came in at -$132.91 million.
- Going back by year, EBITDA was -$130.72 million in FY2024, -$88.06 million in FY2023, -$61.54 million in FY2022 and -$45.34 million in FY2021.
- The five-year range for quarterly EBITDA is -$37.96 million (Q2 2025) to -$13.06 million (Q4 2021).
- Business Quant data shows TCRX's EBITDA at -$28.45 million (Q1 2026), -$23.14 million (Q4 2025) and -$36.29 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,137.66 Bn | 1,106.24 Bn | 19.71 Bn | 12.29 Bn |
| 2 | Johnson & Johnson | 636.13 Bn | 556.00 Bn | 17.30 Bn | 8.30 Bn |
| 3 | AbbVie | 505.28 Bn | 478.39 Bn | 12.70 Bn | 8.33 Bn |
| 4 | Merck | 358.10 Bn | 312.48 Bn | 12.21 Bn | 999.00 Mn |
| 5 | Novartis Ag | 292.59 Bn | 256.58 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 265.81 Bn | 239.50 Bn | 12.86 Bn | 5.09 Bn |
| 7 | Amgen | 237.53 Bn | 192.93 Bn | 7.24 Bn | 4.63 Bn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | -9.70 Bn |
| 9 | Pfizer | 171.17 Bn | 117.82 Bn | 10.94 Bn | 5.89 Bn |
| 10 | TScan Therapeutics | 26.76 Mn | -538.36 Mn | - | -29.79 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -29.79 Mn |
| Mar 31, 2026 | -28.45 Mn |
| Dec 31, 2025 | -23.14 Mn |
| Sep 30, 2025 | -36.29 Mn |
| Jun 30, 2025 | -37.96 Mn |
| Mar 31, 2025 | -35.57 Mn |
| Dec 31, 2024 | -36.00 Mn |
| Sep 30, 2024 | -31.60 Mn |
| Jun 30, 2024 | -33.00 Mn |
| Mar 31, 2024 | -30.12 Mn |
| Dec 31, 2023 | -20.08 Mn |
| Sep 30, 2023 | -23.46 Mn |
| Jun 30, 2023 | -23.31 Mn |
| Mar 31, 2023 | -21.24 Mn |
| Dec 31, 2022 | -17.17 Mn |
| Sep 30, 2022 | -15.33 Mn |
| Jun 30, 2022 | -14.04 Mn |
| Mar 31, 2022 | -14.97 Mn |
| Dec 31, 2021 | -13.06 Mn |
| Sep 30, 2021 | -14.79 Mn |
API Access
TScan Therapeutics EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda&ticker=TCRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda", "ticker": "TCRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda&ticker=TCRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();